US Stock MarketDetailed Quotes
UPB UpStream Bio
- 18.190
- +0.390+2.19%
Close Nov 22 16:00 ET
- 18.190
- 0.0000.00%
Post 16:00 ET
974.92MMarket Cap-14013P/E (TTM)
18.415High17.470Low219.54KVolume17.470Open17.800Pre Close3.92MTurnover1.76%Turnover RatioLossP/E (Static)53.60MShares29.46052wk High-6.08P/B227.38MFloat Cap17.08952wk Low--Dividend TTM12.50MShs Float29.460Historical High--Div YieldTTM5.31%Amplitude17.089Historical Low17.877Avg Price1Lot Size
About UpStream Bio Company
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Company Profile
SymbolUPB
Company NameUpStream Bio
Listing DateOct 11, 2024
Issue Price17.00
Founded2021
CEODr. Everett Rand Sutherland, M.D.
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address890 Winter Street,Suite 200
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-208-2466
Websitehttp://www.upstreambio.com
Company Executives
- Name
- Position
- Salary
- Dr. Everett Rand Sutherland, M.D.
- Chief Executive Officer and Director
- --
- Michael P. Gray
- Chief Financial and Operating Officer
- --
- Dr. Adam Houghton, PhD
- Chief Business Officer
- --
- Dr. Aaron Deykin, M.D.
- Chief Medical Officer and Head of Research and Development
- 823.24K
- Ronald C. Renaud, M.B.A.
- Chairman of the Board
- 208.22K
- Erez Chimovits, M.B.A.,M.Sc.
- Independent Director
- --
- Dr. H. Edward Fleming, M.D.
- Independent Director
- --
- Daniella Beckman
- Independent Director
- --
- Dr. Marcella Kuhlman Ruddy, M.D.
- Independent Director
- 185.33K
- Dr. Liam Ratcliffe, M.D.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
